(COR) Cencora - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03073E1055
COR: Pharmaceuticals, Vaccines, Healthcare, Equipment, Supplies, Software
Cencora, Inc. (NYSE:COR) is a leading player in the healthcare distribution and services industry, operating through two core segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment serves a diverse customer base, including acute care hospitals, retail pharmacies, and long-term care facilities. They provide a wide range of products and services, such as pharmaceuticals, over-the-counter medications, home healthcare equipment, and specialized consulting services like pharmacy management and supply chain optimization. Additionally, they offer packaging solutions, clinical trial support, and data analytics services tailored for pharmaceutical manufacturers. This segment also caters to the veterinary market, supplying products for both companion animals and livestock.
The International Healthcare Solutions segment focuses on global pharmaceutical distribution and commercialization services, serving pharmacies, hospitals, and healthcare providers worldwide. They also provide specialized logistics for biopharmaceuticals, ensuring secure and efficient transportation of sensitive products. Cencoras extensive network and deep industry expertise position it as a critical partner for manufacturers looking to expand their global reach. The company, rebranded from AmerisourceBergen in August 2023, boasts a rich history dating back to 1871 and is headquartered in Conshohocken, Pennsylvania. For more information, visit their website at https://www.cencora.com.
Additional Sources for COR Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
COR Stock Overview
| Market Cap in USD | 48,725m |
| Sector | Healthcare |
| Industry | Medical Distribution |
| GiC Sub-Industry | Health Care Distributors |
| IPO / Inception | 1995-04-04 |
COR Stock Ratings
| Growth 5y | 88.8% |
| Fundamental | 42.4% |
| Dividend | 56.5% |
| Rel. Strength Industry | 8.59 |
| Analysts | 3.94/5 |
| Fair Price Momentum | 295.16 USD |
| Fair Price DCF | 357.56 USD |
COR Dividends
| Dividend Yield 12m | 0.86% |
| Yield on Cost 5y | 2.81% |
| Annual Growth 5y | 4.12% |
| Payout Consistency | 99.6% |
COR Growth Ratios
| Growth Correlation 3m | 81.5% |
| Growth Correlation 12m | 44.7% |
| Growth Correlation 5y | 98.3% |
| CAGR 5y | 27.79% |
| CAGR/Max DD 5y | 1.56 |
| Sharpe Ratio 12m | 0.39 |
| Alpha | 4.23 |
| Beta | 0.17 |
| Volatility | 19.15% |
| Current Volume | 925.1k |
| Average Volume 20d | 1498.7k |
As of March 15, 2025, the stock is trading at USD 258.07 with a total of 925,085 shares traded.
Over the past week, the price has changed by +1.37%, over one month by +6.36%, over three months by +12.55% and over the past year by +9.55%.
Partly, yes. Based on ValueRay Fundamental Analyses, Cencora (NYSE:COR) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 42.37 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of COR as of March 2025 is 295.16. This means that COR is currently undervalued and has a potential upside of +14.37% (Margin of Safety).
Cencora has received a consensus analysts rating of 3.94. Therefor, it is recommend to buy COR.
- Strong Buy: 8
- Buy: 1
- Hold: 7
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, COR Cencora will be worth about 318.8 in March 2026. The stock is currently trading at 258.07. This means that the stock has a potential upside of +23.52%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 278.2 | 7.8% |
| Analysts Target Price | 266.3 | 3.2% |
| ValueRay Target Price | 318.8 | 23.5% |